openPR Logo
Press release

Genetic Disorders Market Anticipated to Nearly Triple in Size by 2030, Boasting 12.2% CAGR

05-20-2024 08:12 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Data Bridge Market Research

/ PR Agency: DBMR
Genetic Disorders Market Anticipated to Nearly Triple in Size

The "Genetic Disorders Market" is a dynamic and rapidly evolving sector, with significant advancements and growth anticipated by 2031. Comprehensive market research reveals a detailed analysis of market size, share, and trends, providing valuable insights into its expansion. This report delves into segmentation and definition, offering a clear understanding of market components and drivers. Employing SWOT and PESTEL analyses, the study evaluates the market's strengths, weaknesses, opportunities, and threats, alongside political, economic, social, technological, environmental, and legal factors. Expert opinions and recent developments highlight the geographical distribution and forecast the market's trajectory, ensuring a robust foundation for strategic planning and investment.

What is the projected market size & growth rate of the Genetic Disorders Market?

Market Analysis and Size

The incidence of genetic disorders such as Down syndrome is caused by an extra copy of chromosome 21, and occurs in approximately 1 in 700 live births in the United States, Sickle cell anemia, is caused by a mutation in the HBB gene, affects approximately 1 in 365 African Americans and Cystic Fibrosis, is caused by mutations in the CFTR gene, affects approximately 1 in 2,500 to 3,500 Caucasian new-borns every year.

Data Bridge Market Research analyses that the genetic disorders market, which was USD 14,954.67 million in 2022, will reach USD 37,559.50 million by 2030 and is expected to grow a CAGR of 12.2% from 2023 to 2030. ""Alzheimer's Disease" dominates the disease type segment of the Genetic Disorders market owing to the growing cases of the disease in the geriatric population. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Browse Detailed TOC, Tables and Figures with Charts which is spread across 350 Pages that provides exclusive data, information, vital statistics, trends, and competitive landscape details in this niche sector.

This research report is the result of an extensive primary and secondary research effort into the Genetic Disorders market. It provides a thorough overview of the market's current and future objectives, along with a competitive analysis of the industry, broken down by application, type and regional trends. It also provides a dashboard overview of the past and present performance of leading companies. A variety of methodologies and analyses are used in the research to ensure accurate and comprehensive information about the Genetic Disorders Market.

Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-genetic-disorders-market

Which are the driving factors of the Genetic Disorders market?

The driving factors of the Genetic Disorders market include technological advancements that enhance product efficiency and user experience, increasing consumer demand driven by changing lifestyle preferences, and favorable government regulations and policies that support market growth. Additionally, rising investment in research and development and the expanding application scope of Genetic Disorders across various industries further propel market expansion.

Genetic Disorders Market - Competitive and Segmentation Analysis:

Global Genetic Disorders Market, By Indication (CF, DMD, LSD, PNH), Disease Type ('Alzheimer's Disease, Cancer, Cystic Fibrosis, Sickle Cell Anaemia, DMD, Thalassemia, 'Huntington's Disease, Rare Diseases, Others) - Industry Trends and Forecast to 2031.

How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Which are the top companies operating in the Genetic Disorders market?

Some of the major players operating in the genetic disorders market are:

Amicus Therapeutics, Inc. (U.S)
Alexion Pharmaceuticals, Inc. (U.S)
Sanofi (France)
Takeda Pharmaceutical Company Limited (Japan)
Vertex Pharmaceuticals Incorporated U.S)
F. Hoffmann-La Roche Ltd (Switzerland)
Abbott (U.S)
Amgen Inc. (U.S)
ELITechGroup (France)
GW Pharmaceuticals plc. (U.K)
Pfizer Inc. (U.S)
PerkinElmer Inc (U.S)
AutoGenomics (U.S)
Bio-Rad Laboratories, Inc. (U.S)
BioMarin (U.S)
Sarepta Therapeutics (U.S)
Short Description About Genetic Disorders Market:

The Global Genetic Disorders market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

North America, especially The United States, will still play an important role which can not be ignored. Any changes from United States might affect the development trend of Genetic Disorders. The market in North America is expected to grow considerably during the forecast period. The high adoption of advanced technology and the presence of large players in this region are likely to create ample growth opportunities for the market.

Europe also play important roles in global market, with a magnificent growth in CAGR During the Forecast period 2024-2031.

Genetic Disorders Market size is projected to reach Multimillion USD by 2031, In comparison to 2024, at unexpected CAGR during 2024-2031.

Despite the presence of intense competition, due to the global recovery trend is clear, investors are still optimistic about this area, and it will still be more new investments entering the field in the future.

This report focuses on the Genetic Disorders in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Get a Sample Copy of the Genetic Disorders Report 2024

What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report. Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users. Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2024-2031) of the following regions are covered in Chapters

What are the key regions in the global Genetic Disorders market?

North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
This Genetic Disorders Market Research/Analysis Report Contains Answers to your following Questions

What are the global trends in the Genetic Disorders market?
Would the market witness an increase or decline in the demand in the coming years?
What is the estimated demand for different types of products in Genetic Disorders?
What are the upcoming industry applications and trends for Genetic Disorders market?
What Are Projections of Global Genetic Disorders Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about Import and Export?
Where will the strategic developments take the industry in the mid to long-term?
What are the factors contributing to the final price of Genetic Disorders?
What are the raw materials used for Genetic Disorders manufacturing?
How big is the opportunity for the Genetic Disorders market?
How will the increasing adoption of Genetic Disorders for mining impact the growth rate of the overall market?
How much is the global Genetic Disorders market worth? What was the value of the market In 2020?
Who are the major players operating in the Genetic Disorders market? Which companies are the front runners?
Which are the recent industry trends that can be implemented to generate additional revenue streams?
What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Genetic Disorders Industry?
Customization of the Report

Can I modify the scope of the report and customize it to suit my requirements? Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Inquire more and share questions if any before the purchase on this report at - https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-genetic-disorders-market

Detailed TOC of Global Genetic Disorders Market Insights and Forecast to 2031

Introduction
Market Segmentation
Executive Summary
Premium Insights
Market Overview
Genetic Disorders Market By Type
Genetic Disorders Market By Function
Genetic Disorders Market By Material
Genetic Disorders Market By End User
Genetic Disorders Market By Region
Genetic Disorders Market: Company Landscape
SWOT Analysis
Company Profiles
Continued...
Purchase this report - https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-genetic-disorders-market

Browse More Reports:

https://databridgeuser.blogspot.com/2024/05/galloway-mowat-syndrome-market-trends.html

https://databridgeuser.blogspot.com/2024/05/smart-greenhouse-market-growth-research.html

https://databridgeuser.blogspot.com/2024/05/distilled-water-market-insights_21.html

https://databridgeuser.blogspot.com/2024/05/pediatric-electronic-medical-records.html

https://databridgeuser.blogspot.com/2024/05/grasshoppers-protein-market-2024-growth.html

https://databridgeuser.blogspot.com/2024/05/home-care-providers-market-region.html

https://databridgeuser.blogspot.com/2024/05/pneumatic-components-and-systems-market.html

https://databridgeuser.blogspot.com/2024/05/original-equipment-manufacturer-oem_21.html

https://databridgeuser.blogspot.com/2024/05/sternal-closure-systems-market-trends.html

https://databridgeuser.blogspot.com/2024/05/how-styrene-butadiene-rubber-sbr-market.html

Data Bridge Market Research:

Today's trends are a great way to predict future events!

Data Bridge Market Research is a market research and consulting company that stands out for its innovative and distinctive approach, as well as its unmatched resilience and integrated methods. We are dedicated to identifying the best market opportunities, and providing insightful information that will help your business thrive in the marketplace. Data Bridge offers tailored solutions to complex business challenges. This facilitates a smooth decision-making process. Data Bridge was founded in Pune in 2015. It is the product of deep wisdom and experience.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 975

Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Genetic Disorders Market Anticipated to Nearly Triple in Size by 2030, Boasting 12.2% CAGR here

News-ID: 3504524 • Views:

More Releases from Data Bridge Market Research

Vaccine Adjuvants Market to Observe Highest Growth of USD 2,950.57 million with an Excellent CAGR of 13.37% by 2030
Vaccine Adjuvants Market to Observe Highest Growth of USD 2,950.57 million with …
Vaccine Adjuvants Market survey report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. Client or business can get aware of the impact of opportunities that are offered by the market and hence design sustainable and competitive strategies in times of rapid development. A range of definitions and classification of the Vaccine Adjuvants
Nutraceutical Excipients Market to Observe Highest Growth of USD 3,685.86 million with an Excellent CAGR of 7.4% by 2030
Nutraceutical Excipients Market to Observe Highest Growth of USD 3,685.86 millio …
Nutraceutical Excipients Market survey report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. Analysis and estimation of important industry trends, market size, and market share are mentioned in the market report. The usefulness of SWOT analysis and Porter's Five Forces analysis in generating market research report makes it preferable by the businesses
Benzene Market to Observe Highest Growth of USD 62.55 billion with an Excellent CAGR of 3.0% by 2030
Benzene Market to Observe Highest Growth of USD 62.55 billion with an Excellent …
Data Bridge Market research has recently released expansive research titled Global Benzene Market guarantees you will remain better informed than your competition. Benzene Market report gives explanation about the different segments of the market analysis which is demanded by today's businesses. Key players are taking actions such as developments, product launches, acquisitions, mergers, joint ventures and competitive analysis in the industry. All the market aspects are estimated and analysed
Breast Cancer Liquid Biopsy Market to Observe Highest Growth of USD 278.07 million with an Excellent CAGR of 23.09% by 2030
Breast Cancer Liquid Biopsy Market to Observe Highest Growth of USD 278.07 milli …
Global Breast Cancer Liquid Biopsy Market study by Data Bridge Market Research provides details about the market dynamics affecting the Breast Cancer Liquid Biopsy market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. Breast Cancer Liquid Biopsy market analysis report is the high quality report having in-depth market research studies. For dominating the market or industry

All 5 Releases


More Releases for Genetic

Genetic Testing Market to Register Growth due to Increasing Prevalence of Geneti …
The prevalence of diseases, including chronic and genetic diseases, is rising at a swift pace. According to the World Health Organization, a genetic disorder named sickle cell anemia is primarily common among people who had ancestors in India, South America, Central America, Sub-Saharan Africa, Mediterranean countries (including Greece, Turkey, and Italy), Cuba, and Saudi Arabia. In addition to this, the high prevalence of chronic diseases, such as cancer, is also
Genetic Testing Market Demand 2018; by Method Molecular Genetic Test/ DNA Test, …
Universal Genetic Testing Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Genetic Testing market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023. Genetic Testing Market - Global Insights The Global Genetic Testing Market is growing with the rapid
Global Preimplantation Genetic Testing Market: Growing Public-Private Investment …
The report "Preimplantation Genetic Testing Market by Products & Services (Reagents and Consumables, Software and Services and Instruments), Technology (Single-Nucleotide Polymorphism, Next-Generation Sequencing, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization and Polymerase Chain Reaction), Procedure Type (Preimplantation Genetic Screening, and Preimplantation Genetic Diagnosis), Application (Single Gene Disorders, HLA Typing, Structural Chromosomal Abnormalities, X-Linked Disorders, Aneuploidy and Gender Identification), End User (Hospitals, Diagnostic Labs, and Service Providers, Research Laboratories & Academic
Reproductive Genetic Innovations to Discuss Novelties in Preimplantation Genetic …
Reproductive Genetic Innovations (RGI) will be attending and presenting at the 54th Mexican Congress of Reproductive Medicine hosted by the Associacion Mexicana de Medicina de la Reproduccion, A.C. (AMMR). This is the first year RGI has attended and presented at this conference. Booth G-H (July 17th to the 20th) President and Lab Director, Dr. Svetlana Rechitsky, will be giving a lecture on Wednesday afternoon (July 19th) titled, "Novelties in
Breast Cancer Predictive Genetic Testing Market Breast Cancer Predictive Genetic …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Cancer Susceptibility Testing 1.1 Prologue to Cancer Susceptibility 1.2 Aspects of Cancer Susceptibility Testing Breast Cancer Susceptibility 2.1 Conceptual of Breast Cancer Susceptibility 2.2 Trail of the Inherited Susceptible Genes Hereditary Breast Cancer Genes 3.1 High Penetrant Genes 3.1.1 Breast Cancer Gene1 (BRCA1) 3.1.2 Breast Cancer Gene 2 (BRCA2)
Rising Prevalence of Genetic Disorders Propels Prenatal and New-born Genetic Tes …
Global Prenatal and New-born Genetic Testing Market: Snapshot Prenatal and new-born genetic tests refer to the systematic diagnostic tests and screenings undertaken to determine the risk of certain genetic disorders in newborn children and fetuses in stages as early as eight to ten weeks of gestation. The use of a variety of screening and diagnostic tools for detecting chromosomal abnormalities and the risk of diseases such as Patau syndrome, Down